Disease burden of prostate cancer from 2014 to 2019 in the United States: estimation from the Global Burden of Disease Study 2019 and Medical Expenditure Panel Survey.

ABSTRACT:

Objectives

The aim of this study was to evaluate the disease burden of prostate cancer (PC) and assess key influencing factors associated with the disease expenditures of PC in the United States.

Methods

The total deaths, incidence, prevalence, and disability-adjusted life-years of PC were obtained from the Global Burden of Disease Study 2019. The Medical Expenditure Panel Survey was used to estimate healthcare expenditures and productivity loss and to investigate patterns of payment and use of healthcare resources in the United States. A multivariable logistic regression model was conducted to identify key factors influencing expenditures.

Results

For patients aged 50 and older, the burden for all age groups showed a modest increase over the 6-year period. Annual med

SUBMITTER: Lin S 

PROVIDER: S-EPMC10586921 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature